Select Conferences

Proxeon and Varian Announce OEM Agreement
Varian to offer Proxeon's EASY-nLC, a nanoscale chromatography system, as part of their LC/MS portfolio.

The Nanoethics Group Publishes Anthology with Springer
New volume addresses a range of near-term issues related to nanotechnology’s ethical and social implications.

Calando Receives FDA Approval for Phase I Clinical Trial Using a Targeted siRNA Nanoparticle Therapeutic
FDA approval to proceed with proprietary RONDEL™ drug delivery system and siRNA combined for first targeted, systemic delivery in oncology phase I clinical trial.

Virtual Discovery Europe, Amsterdam, The Netherlands
19 June 2008 - 20 June 2008

This is the second annual Virtual Discovery Europe conference and exhibition. This meeting will be focusing on computer-aided drug design and screening. Topics to be covered are Virtual Screening, Computational Chemistry, Lead Identification and Optimisation, New Algorithms and Technologies and Chemoinformatics. Confirmed speakers are Prof. Wolfgang Sippl from Martin Luther University and Prof. Maurizio Botta of the University of Siena.

European Biomarkers Summit, Lisbon, Portugal
16 October 2008 - 17 October 2008

Welcome to the 3rd annual European Biomarkers Summit. This year's event will take place in the historic city of Lisbon.

The conference will be co-located with Advances in Metabolic Profiling and Proteomics Europe. Registered delegates will have access to all three meetings ensuring a very cost-effective trip.

Permanent Senior Scientist Position in NMR-based Metabolomics
CIBERDEM
Tarragona, Spain

BBSRC Funded Microfluidics Engineering Resarch PhD
University College London
London, UK

Post-Doctpral Position in Mollusk Health Laboratory
UPEI
Charlottetown, Canada

Production Chemist II
Independent
Torrance, CA, USA

Research Chemist
Independent
Torrance, CA, USA

phD Scholarship in BioInformatics
Universitat Rovira i Virgili
Tarragona, Spain

QC Analyst
Genomic Health
Redwood City, CA, USA

Characterization of nanosecond micro-mixers
1Section Enzymology – Department of Biotechnology – Delft University of Technology, Julianalaan 67, 2628 BC Delft, The Netherlands; 2MESA+ Research Institute - University of Twente, 7500 AE Enschede,

We have constructed two four-jet-tangential micro-mixers, one from stainless-steel to study reactions in a freeze-quench setup, instrumental-dead-time 60µs and one from glass allowing optical studies. Both mixers contain 70µm channels ending in premixing-chamber. After the premixing-chamber, the fluids enter a mixing-chamber and leaves at an orifice travelling further as a free jet, mixing-time 200 ns, jet flow 200 m/s, pressure 400 bar.

Modular Glass Chip System for the Acquisition of the Electric Activity and Physiological Parameters of Differentiated Stem Cells
University of Rostock

The EU chemical policy REACH, effective on June 2007, regulates the registration, evaluation and authorization of chemicals. Investigations on the effects of neurotoxic and developmental-neurotoxic substances are required by European and US-American test guidelines. However, at the moment these tests are based on animal experiments contradicting society claims to abolish animal experiments and to implement the 3R-principle. The resulting problem is… How to pair REACH and the 3Rs?
  

Nanomedicine 2006-2011
Published June 2006

The purpose of this report is to examine the commercial prospects of nanotechnology in medicine – the fast-developing and increasingly lucrative field of nanomedicine. Nanotechnology has great potential to benefit - even revolutionise - the pharmaceutical, medical devices, diagnostics and imaging sectors.

World Guide to Bionanotechnology Industry and its Progression
Published October 2005

Nanotechnology, or the science of the small, holds enormous promise across all industries, not at least in life science. Since mid 90th there has been increasing intersection of two important scientific fields, nanotechnology and biotechnology, hence the name bionanotechnology.

The Impact of Nanotechnology in Drug Discovery
Published April 2005

This report discusses how nano-enabled discovery and validation technologies can expand the hit rate for promising compounds in the pipeline, and expedite their progress through to market.